I’m the Sickle Cell and Thalassaemia Screening Lead at Northampton General Hospital and Kettering General Hospital. For the past year I’ve been on secondment as national project lead for the NHS Sickle Cell and Thalassaemia (SCT) Screening Programme.
NHS Sickle Cell and Thalassaemia Screening Programme
We’ve now published the screening key performance indicator (KPI) data for the fourth quarter of 2016 to 2017 (Q4, January to March 2017). The KPIs are used to measure how NHS screening programmes are performing and aim to give a high level overview of programme quality.
NHS England has published the 2017-18 service specifications for all 11 NHS Screening Programmes. The specifications accompany the 2017-18 agreement that outlines how NHS England commissions certain public health services under section 7A of the National Health Service Act 2006.
Today we published the key performance indicator (KPI) templates for the first quarter of 2017 to 2018. This covers the period 1 April to 30 June 2017. Data collection is from maternity services and child health information systems (CHIS).
We have published new information that describes the checks and audits that are needed for the sickle cell and thalassaemia (SCT) screening pathway.
I’m the antenatal and newborn screening coordinator at Northampton General Hospital. That means I’m responsible for making sure we offer and carry out all antenatal and newborn screening tests correctly for mothers and babies in our care.
We use key performance indicator (KPI) data to measure how the NHS screening programmes are performing.
We offer screening for sickle cell and thalassaemia (SCT) to all pregnant women. We also offer to screen the baby’s biological father if the mother is found to be a carrier of or have a sickle cell or thalassaemia condition.
Our 3 antenatal screening programmes have joined forces with the national Screening Quality Assurance Service (SQAS) team to hold 8 regional workshops during 2017.
Are you involved in antenatal sickle cell and thalassaemia (SCT) screening? Do you counsel women and couples at risk of having a baby with a significant haemoglobin disorder? Are you aware of all the resources available to support your counselling?